Legend

Name: Legend

Caution

Federal law restricts this drug to use by or on the order of a licensed veterinarian.

Description

Legend® (hyaluronate sodium) Injectable Solution is a clear, colorless solution of low viscosity. Legend Injectable Solution is pyrogen free, sterile and does not contain a preservative. It is administered by intravenous or intra-articular injection. `

Hyaluronic acid, the conjugate acid of hyaluronate sodium, is extracted from the capsule of Streptococcus spp. and purified, resulting in a form which is essentially free of protein and nucleic acids.

Legend Injectable Solution is supplied in 2 mL (20 mg) vials. Each mL contains 10 mg hyaluronate sodium, 8.5 mg sodium chloride, 0.223 mg sodium phosphate dibasic, and 0.04 mg sodium phosphate monobasic. The pH is adjusted to between 6.5 and 8.0 with sodium hydroxide or hydrochloric acid.

Chemistry

Hyaluronic acid, a glycosaminoglycan, can exist in the following forms depending upon the chemical environment in which it is found: as the acid, hyaluronic acid; as the sodium salt, sodium hyaluronate (hyaluronate sodium); or as the hyaluronate anion. These terms may be used interchangeably but in all cases, reference is made to the glycosaminoglycan composed of repeating subunits of D-glucuronic acid and N-acetyl-D-glucosamine linked together by glycosidic bonds. Since this product originates from a microbial source, there is no potential for contamination with dermatan or chondroitin sulfate or any other glycosaminoglycan.

Adverse reactions

No local or systemic side effects were observed in the clinical field trials with either intravenous or intra-articular injections.

Post-Approval Experience: While all adverse reactions are not reported, the following adverse reactions are based on voluntary post-approval reporting:

Following intravenous use: Occasional depression, lethargy, and fever.

Following intra-articular use: lameness, joint effusion, joint or injection site swelling, and joint pain.

For medical emergencies or to report adverse reactions, call 1-800-422-9874.

Reference

1Swanstrom, O.G. 1978. Hyaluronate (hyaluronic acid) and its use, Proc. American Assoc. Equine Pract., 24th annual convention, pp. 345-348.

U.S. Patent No. 4,808,576

For customer service or to obtain product information, including a Material Safety Data Sheet, call 1-800-633-3796.

08710980-017599

Made in U.S.A.

September, 2005

08715516-79001750, R.11

NADA 140-883, Approved by FDA

Bayer, the Bayer Cross, Legend and the horse logo are trademarks of Bayer.

© 2005 Bayer HealthCare LLC

12827

Product Label

Legend® (hyaluronate sodium) Injectable Solution 10mg/mL 2mL

For Intravenous Use in Horses Only

Read Package Insert for Details

Legend 
hyaluronate sodium injection, solution
Product Information
Product Type PRESCRIPTION ANIMAL DRUG Item Code (Source) NDC:00859-2272
Route of Administration INTRAVENOUS, INTRA-ARTICULAR DEA Schedule     
Active Ingredient/Active Moiety
Ingredient Name Basis of Strength Strength
HYALURONATE SODIUM (HYALURONIC ACID) HYALURONATE SODIUM 10 mg  in 1 mL
Inactive Ingredients
Ingredient Name Strength
SODIUM CHLORIDE 8.5 mg  in 1 mL
SODIUM PHOSPHATE, DIBASIC 0.223 mg  in 1 mL
SODIUM PHOSPHATE, MONOBASIC 0.04 mg  in 1 mL
Packaging
# Item Code Package Description
1 NDC:00859-2272-1 6 BOTTLE (BOTTLE) in 1 CARTON
1 2 mL in 1 BOTTLE
Marketing Information
Marketing Category Application Number or Monograph Citation Marketing Start Date Marketing End Date
NADA NADA140883 09/12/1991
Labeler - Bayer HealthCare LLC Animal Health Division (152266193)
Revised: 05/2009   Bayer HealthCare LLC Animal Health Division
(web3)